1Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs [ J ]. Nat New Biol, 1971,231(25) :232 -235.
2Xie WL, Chipman JG, Robertson DL, et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing [ J]. Proc Nail Acad Sci USA, 1991,88(7) :2692 -2696.
3Warner TD, Giuliano F, VojNovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenases-1 rather than cyclooxygenase-2 are associated with gastrointestinal toxicity:A full in vitro analysis [ J ]. Proc Natl Acad Sci USA,1999,96 ( 13 ): 7563 - 7568.
4FitzGerald GA. Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations [J]. Am J Cardiol, 2002,89(6A) :26D - 32D.
5Khan KN, Paulson SK, VerBurg KM, et al.Pharmacology of cyclooxygenase-2 inhibition in the kidney[J]. Kidney Int, 2002,61(4) :1210 - 1219.
6Waener TD, Mitchell JA. Cyclooxygenase-3 ( COX-3 ):filling in the gaps toward a COX continuum.? [ J ]. Proc Natl Acad Sci USA, 2002,99 (21): 13371 - 13373.
7Vane JR. Biomedicine. Back to an aspirin a day? [J]Science, 2002,296 (5567) :474 - 475.
9Mitchell JA, Akarasereenont P, Thiemermann C, et al.Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase[J]. Proc Natl Acad Sci USA, 1993,90(24) :11693 -11697.
10de Leval X, Delarge J, Somers F, et al. Recent advances in inducible cyclooxygenase ( COX-2 ) inhibition [ J ].Curr Med Chem, 2000,7(10) :1041 -1062.
